Page 6 - Adpt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Platinum Investment Management Ltd. lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 39.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 366,230 shares of the company’s stock after buying an additional 102,739 shares during the quarter. […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) CFO Tycho Peterson sold 38,000 shares of Adaptive Biotechnologies stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $7.16, for a total value of $272,080.00. Following the sale, the chief financial officer now owns 454,891 shares in the company, valued […]

Jennison Associates LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 11.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 195,036 shares of the company’s stock after acquiring an additional 20,745 shares during the period. Jennison Associates LLC […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price lifted by Piper Sandler from $14.00 to $15.00 in a report released on Monday morning, The Fly reports. A number of other analysts also recently issued reports on ADPT. Credit Suisse Group reiterated an underperform rating and issued a $7.00 price target on shares of […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) – Investment analysts at William Blair lifted their Q2 2023 earnings estimates for Adaptive Biotechnologies in a report issued on Thursday, May 4th. William Blair analyst A. Brackmann now forecasts that the company will post earnings of ($0.31) per share for the quarter, up from their previous estimate […]